Skip to main content

Seven Bridges Raises $15M in First Closing of Series C

NEW YORK – Seven Bridges Genomics said Tuesday that it has raised $15 million from a new investor in the first closing of a planned $30 million Series C round of venture capital. The Boston-based multiomic bioinformatics company did not disclose the name of the investor but said it was a new shareholder that works in life sciences.

Seven Bridges said that the second half of the round is expected to close before the end of the second quarter.

"Multiomics tools are fast becoming ubiquitous drivers of scientific innovation," Seven Bridges CEO William Moss said in a statement. "This new investment … will help us continue to innovate and scale our organization to serve our customers’ rapidly evolving needs to utilize multiomics data in their research."

The firm has brought in about $113 million in venture capital since its inception in 2009. Seven Bridges raised $3 million in a seed round in 2014, $45 million in a Series A round in 2016, and $50 million in a Series B round in 2018.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.